This system intakes 3 view mammogram scans of breast tissue and outputs the risk factors associated with the images. It improves on the current clinical accuracy of risk assessment by more than 10% in the majority demographic (caucasian women) and up to 60% improvement in the case of minority demographics. We adapted just released research into a production grade AI system and helped oversee and advise the process for technology acceptance by the FDA.